Emberton M - Search Results

1

Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-analysis.

Kasivisvanathan V, Stabile A, Neves JB, Giganti F, Valerio M, Shanmugabavan Y, Clement KD, Sarkar D, Philippou Y, Thurtle D, Deeks J, Emberton M, Takwoingi Y, Moore CM. Kasivisvanathan V, et al. Among authors: emberton m. Eur Urol. 2019 Sep;76(3):284-303. doi: 10.1016/j.eururo.2019.04.043. Epub 2019 May 24. Eur Urol. 2019. PMID: 31130434

2

The progression of benign prostatic hyperplasia: examining the evidence and determining the risk.

Anderson JB, Roehrborn CG, Schalken JA, Emberton M. Anderson JB, et al. Among authors: emberton m. Eur Urol. 2001 Apr;39(4):390-9. doi: 10.1159/000052475. Eur Urol. 2001. PMID: 11306876 Review.

3

Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study.

Nathan TR, Whitelaw DE, Chang SC, Lees WR, Ripley PM, Payne H, Jones L, Parkinson MC, Emberton M, Gillams AR, Mundy AR, Bown SG. Nathan TR, et al. Among authors: emberton m. J Urol. 2002 Oct;168(4 Pt 1):1427-32. doi: 10.1016/S0022-5347(05)64466-7. J Urol. 2002. PMID: 12352410 Clinical Trial.

4

The patient's dilemma: prostate cancer treatment choices.

Patel HR, Mirsadraee S, Emberton M. Patel HR, et al. Among authors: emberton m. J Urol. 2003 Mar;169(3):828-33. doi: 10.1097/01.ju.0000052056.27609.8a. J Urol. 2003. PMID: 12576794 Review.

5

Benign prostatic hyperplasia: a progressive disease of aging men.

Emberton M, Andriole GL, de la Rosette J, Djavan B, Hoefner K, Vela Navarrete R, Nordling J, Roehrborn C, Schulman C, Teillac P, Tubaro A, Nickel JC. Emberton M, et al. Urology. 2003 Feb;61(2):267-73. doi: 10.1016/s0090-4295(02)02371-3. Urology. 2003. PMID: 12597928 Review. No abstract available.

6

Classic papers in Urology.

Thomas K, Moore CM, Gerharz EW, O'Brien T, Emberton M. Thomas K, et al. Among authors: emberton m. Eur Urol. 2003 Jun;43(6):591-5. doi: 10.1016/s0302-2838(03)00143-x. Eur Urol. 2003. PMID: 12767357

7

EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).

Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ. Madersbacher S, et al. Among authors: emberton m. Eur Urol. 2004 Nov;46(5):547-54. doi: 10.1016/j.eururo.2004.07.016. Eur Urol. 2004. PMID: 15474261

8

Does photodynamic therapy have the necessary attributes to become a future treatment for organ-confined prostate cancer?

Moore CM, Hoh IM, Bown SG, Emberton M. Moore CM, et al. Among authors: emberton m. BJU Int. 2005 Oct;96(6):754-8. doi: 10.1111/j.1464-410X.2005.05709.x. BJU Int. 2005. PMID: 16153193 Review. No abstract available.

9

Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer.

Moore CM, Nathan TR, Lees WR, Mosse CA, Freeman A, Emberton M, Bown SG. Moore CM, et al. Among authors: emberton m. Lasers Surg Med. 2006 Jun;38(5):356-63. doi: 10.1002/lsm.20275. Lasers Surg Med. 2006. PMID: 16392142 Clinical Trial.

10

How good is MRI at detecting and characterising cancer within the prostate?

Kirkham AP, Emberton M, Allen C. Kirkham AP, et al. Among authors: emberton m. Eur Urol. 2006 Dec;50(6):1163-74; discussion 1175. doi: 10.1016/j.eururo.2006.06.025. Epub 2006 Jun 30. Eur Urol. 2006. PMID: 16842903 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

561 results

Search Page